{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05259527",
            "orgStudyIdInfo": {
                "id": "MCC-21-18386"
            },
            "secondaryIdInfos": [
                {
                    "id": "HM20023717",
                    "type": "OTHER",
                    "domain": "Virginia Commonwealth University"
                }
            ],
            "organization": {
                "fullName": "Virginia Commonwealth University",
                "class": "OTHER"
            },
            "briefTitle": "Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy",
            "officialTitle": "Impact of Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy",
            "therapeuticArea": [
                "Other"
            ],
            "study": "vitamin-d-supplementation-on-reported-rates-of-taxane-induced-neuropathy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-12-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-03-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-03-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-02-17",
            "studyFirstSubmitQcDate": "2022-02-17",
            "studyFirstPostDateStruct": {
                "date": "2022-02-28",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-17",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Virginia Commonwealth University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This is a two-arm randomized clinical trial in which 80 participants with Vitamin D deficiency and scheduled to begin taxane-based chemotherapy will be randomized to either: 1) prescribed vitamin D replacement or 2) standard of care.",
            "detailedDescription": "This is a two-arm randomized clinical trial in which 80 participants with Vitamin D deficiency and scheduled to begin taxane-based chemotherapy will be randomized to either: 1) prescribed vitamin D replacement or 2) standard of care (advised to take over the counter (OTC) vitamin D).\n\nAll participants will have blood drawn for serum vitamin D analysis at Weeks 4, 8, 12, and 24 in order to document Vitamin D levels and titrate vitamin D dose (if needed in the treatment arm). Participants in both arms will complete self-report measures of neuropathic pain at baseline, Week 12, and Week 24."
        },
        "conditionsModule": {
            "conditions": [
                "Neuropathic Pain"
            ],
            "keywords": [
                "Neuropathic pain",
                "Neuropathy",
                "Vitamin-D"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 120,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Vitamin D Replacement",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive prescribed oral vitamin D2 to achieve a serum vitamin D level between 30 ng/mL to 50 ng/mL.",
                    "interventionNames": [
                        "Drug: Ergocalciferol Capsules"
                    ]
                },
                {
                    "label": "Standard of Care",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive standard-of-care advice to take over the counter vitamin D.",
                    "interventionNames": [
                        "Dietary Supplement: Cholecalciferol Capsules"
                    ]
                },
                {
                    "label": "Observation Arm",
                    "type": "NO_INTERVENTION",
                    "description": "Observation only"
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ergocalciferol Capsules",
                    "description": "Vitamin D2 50,000IU by mouth once weekly for 8 weeks then once per month thereafter.",
                    "armGroupLabels": [
                        "Vitamin D Replacement"
                    ],
                    "otherNames": [
                        "Vitamin D2"
                    ]
                },
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Cholecalciferol Capsules",
                    "description": "Vitamin D3 5,000IU by mouth daily",
                    "armGroupLabels": [
                        "Standard of Care"
                    ],
                    "otherNames": [
                        "Over the Counter Vitamin D3"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Self-reported neuropathic pain- sensory symptoms",
                    "description": "The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-CIPN (EORTC-QLQ-CIPN20) is a 20-item self-report questionnaire that includes a 9-item subscale assessing sensory symptoms of peripheral neuropathy. The questionnaire asks respondents to think about their past week and indicate to what extent they experienced symptoms of peripheral neuropathy: not at all; a little; quite a bit; or very much. The EORTC-QLQ-CIPN20 will be administered at baseline and at 12 weeks in order to assess change in scores over time.",
                    "timeFrame": "12 Weeks"
                },
                {
                    "measure": "Self-reported neuropathic pain- motor symptoms",
                    "description": "The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-CIPN (EORTC-QLQ-CIPN20) is a 20-item self-report questionnaire that includes a 8-item subscale assessing motor symptoms of peripheral neuropathy. The questionnaire asks respondents to think about their past week and indicate to what extent they experienced symptoms of peripheral neuropathy: not at all; a little; quite a bit; or very much. The EORTC-QLQ-CIPN20 will be administered at baseline and at 12 weeks in order to assess change in scores over time.",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Self-reported neuropathic pain- autonomic symptoms",
                    "description": "The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-CIPN (EORTC-QLQ-CIPN20) is a 20-item self-report questionnaire that includes a 3-item subscale assessing autonomic symptoms of peripheral neuropathy. The questionnaire asks respondents to think about their past week and indicate to what extent they experienced symptoms of peripheral neuropathy: not at all; a little; quite a bit; or very much. The EORTC-QLQ-CIPN20 will be administered at baseline and at 12 weeks in order to assess change in scores over time.",
                    "timeFrame": "12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Self-reported neuropathic pain",
                    "description": "The number of participants with self reported neuropathic pain using the PROMIS Scale v. 2.0 - Neuropathic Pain Quality 5a. This 5-item questionnaire asks respondents to indicate the extent to which they experienced symptoms of peripheral neuropathy in the past week on a scale from 1 (\"not at all\") to 5 (\"very much\"). The PROMIS Scale v. 2.0 - Neuropathic Pain Quality 5a will be administered at baseline and at 12 weeks in order to assess change in scores over time.",
                    "timeFrame": "12 Weeks"
                },
                {
                    "measure": "Clinical diagnosis of peripheral neuropathy",
                    "description": "The number of participants with a clinical diagnosis of peripheral neuropathy. Chart review will be performed in order to determine whether an independent clinical diagnosis of peripheral neuropathy has been made for study participants.",
                    "timeFrame": "12 Weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of stage I-III cancer of any type, OR diagnosis of stage IV cancer being treated with curative intent\n* Receiving or scheduled to begin taxane-based chemotherapy at Virginia Commonwealth University (VCU) Health Massey Comprehensive Cancer Center\n* Vitamin D serum level \\<20 ng/mL Note: study participants with Vitamin D serum level \u226520 ng/mL may be enrolled in the observational arm.\n\nExclusion Criteria:\n\n* Pre-existing diagnosis of neuropathy\n* Currently taking prescription Vitamin D (ergocalciferol)\n* Inability to converse in English\n* Pregnancy\n* Chronic kidney disease (stage IV or greater)\n* Known hyperparathyroidism\n* Hypercalcemia: Calcium levels \\>10.5 mg/dL Note: study participants with calcium levels \\<10.5 mg/dL may be enrolled in the observational arm.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Autumn Lanoye, PhD",
                    "role": "CONTACT",
                    "phone": "804-828-4929",
                    "email": "lanoyeam@vcu.edu"
                },
                {
                    "name": "Susan Hong, MD",
                    "role": "CONTACT",
                    "email": "susan.hong@vcuhealth.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Susan Hong, MD",
                    "affiliation": "Virginia Commonwealth University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Virginia Commonwealth University",
                    "status": "RECRUITING",
                    "city": "Richmond",
                    "state": "Virginia",
                    "zip": "23286",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Autumn Lanoye, PhD",
                            "role": "CONTACT",
                            "phone": "804-828-4929",
                            "email": "autumn.lanoye@vcuhealth.org"
                        },
                        {
                            "name": "Susan Hong, MD",
                            "role": "CONTACT",
                            "email": "susan.hong@vcuhealth.org"
                        },
                        {
                            "name": "Susan Hong, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.55376,
                        "lon": -77.46026
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "There are no plans to make individual participant data (IPD) available to other researchers at this time."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009437",
                    "term": "Neuralgia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010523",
                    "term": "Peripheral Nervous System Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000010146",
                    "term": "Pain"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M12381",
                    "name": "Neuralgia",
                    "asFound": "Neuropathic Pain",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13432",
                    "name": "Peripheral Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014807",
                    "term": "Vitamin D"
                },
                {
                    "id": "D000004872",
                    "term": "Ergocalciferols"
                },
                {
                    "id": "D000002762",
                    "term": "Cholecalciferol"
                },
                {
                    "id": "D000014815",
                    "term": "Vitamins"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018977",
                    "term": "Micronutrients"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000050071",
                    "term": "Bone Density Conservation Agents"
                },
                {
                    "id": "D000077264",
                    "term": "Calcium-Regulating Hormones and Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17558",
                    "name": "Vitamins",
                    "asFound": "Two",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17550",
                    "name": "Vitamin D",
                    "asFound": "Acid",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8026",
                    "name": "Ergocalciferols",
                    "asFound": "Acid",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6003",
                    "name": "Cholecalciferol",
                    "asFound": "Acid",
                    "relevance": "HIGH"
                },
                {
                    "id": "M147959",
                    "name": "Taxane",
                    "relevance": "LOW"
                },
                {
                    "id": "M21009",
                    "name": "Micronutrients",
                    "relevance": "LOW"
                },
                {
                    "id": "M16885",
                    "name": "Trace Elements",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "T440",
                    "name": "Calciferol",
                    "asFound": "Acid",
                    "relevance": "HIGH"
                },
                {
                    "id": "T445",
                    "name": "Ergocalciferol",
                    "asFound": "Acid",
                    "relevance": "HIGH"
                },
                {
                    "id": "T478",
                    "name": "Vitamin D2",
                    "asFound": "Acid",
                    "relevance": "HIGH"
                },
                {
                    "id": "T442",
                    "name": "Cholecalciferol",
                    "asFound": "Acid",
                    "relevance": "HIGH"
                },
                {
                    "id": "T479",
                    "name": "Vitamin D3",
                    "asFound": "Acid",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}